scientifyRESEARCH
research funding database

RESEARCH FUNDER

National Institutes of Health (NIH)

Share

The National Institutes of Health (NIH) is the primary agency funded by the US government for biomedical and public health research. The Institutes provide extramural research funding for biomedical researchers, primarily in the USA and some awards for international researchers.

Open Access Policy: The NIH Public Access policy requires that all grantees submit or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final, peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. Publication costs, including author fees, may be charged to NIH grants and contracts on three conditions: (1) such costs incurred are actual, allowable, and reasonable to advance the objectives of the award; (2) costs are charged consistently regardless of the source of support; (3) all other applicable rules on allowability of costs are met.

Funder location: 
Activity location: 
Recipient citizenship: 

Related Grant Opportunities

NCI Outstanding Investigator Award (cancer research | USA)

Letter of intent: October 7, 2024

Final closing date: November 7, 2024

Genomic Community Resources (worldwide)

Letter of intent: July 27, 2024

Final closing date: September 25, 2024

Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (USA)

Letter of intent: July 13, 2024

Final closing date: August 13, 2024

International Research in Infectious Diseases (developing countries)

Letter of intent: July 2, 2024

Final closing date: August 2, 2024

NIMH Short Courses for Mental Health Related Research (USA)

Letter of intent: April 25, 2024

Final closing date: May 25, 2024

NIMH Research Education Programs for Psychiatry Residents (USA)

Letter of intent: April 25, 2024

Final closing date: May 25, 2024

NIMH Mentoring Networks for Mental Health Research Education (USA)

Letter of intent: April 25, 2024

Final closing date: May 25, 2024

Undergraduate Scholarship Program (USA)

Final closing date: March 29, 2024

Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 16, 2024

BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 13, 2024

Mentored Patient-Oriented Research Career Development Award (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 12, 2024

Mentored Clinical Scientist Research Career Development Award (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 12, 2024

Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: January 8, 2024

Final closing date: February 8, 2024

Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 5, 2024

Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: January 5, 2024

Final closing date: February 5, 2024

Research Project Grant (Parent R01 Clinical Trial Required) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 5, 2024

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 5, 2024

Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 5, 2024

NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) (worldwide | aging research)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 5, 2024

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: February 5, 2024

Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: January 2, 2024

Final closing date: February 2, 2024

Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: January 2, 2024

Final closing date: February 2, 2024

Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: December 26, 2023

Final closing date: January 26, 2024

NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: December 24, 2023

Final closing date: January 24, 2024

NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: December 8, 2023

Ruth L. Kirschstein National Research Service Awards for Senior Fellows (USA biomedical researchers)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: December 8, 2023

Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: November 1, 2023

Final closing date: December 1, 2023

Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 29, 2023

Final closing date: November 29, 2023

Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) (USA + developing countries)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 15, 2023

Final closing date: November 15, 2023

NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 14, 2023

Final closing date: November 14, 2023

Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 13, 2023

Final closing date: November 13, 2023

Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 13, 2023

Final closing date: November 13, 2023

Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 10, 2023

Final closing date: November 9, 2023

Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 7, 2023

Final closing date: November 7, 2023

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: November 3, 2023

Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 3, 2023

Final closing date: November 3, 2023

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: November 3, 2023

Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 3, 2023

Final closing date: November 3, 2023

Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 2, 2023

Final closing date: November 2, 2023

Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: October 1, 2023

Final closing date: November 1, 2023

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed | USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 17, 2023

Final closing date: October 27, 2023

Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies Grant (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 26, 2023

Final closing date: October 26, 2023

Paul B. Beeson Emerging Leaders Career Development Award in Aging (USA | clinical trial)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 20, 2023

Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 – Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 20, 2023

Final closing date: October 20, 2023

Interventions to Integrate Social Care and Medical Care to Improve Health Equity (R01 Clinical Trial Required) (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 19, 2023

Final closing date: October 19, 2023

Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 19, 2023

The Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 19, 2023

The Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed | USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 17, 2023

Final closing date: October 17, 2023

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 17, 2023

Final closing date: October 17, 2023

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 16, 2023

Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 16, 2023

Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 16, 2023

BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 13, 2023

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 12, 2023

Final closing date: October 13, 2023

BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent:

Final closing date: October 13, 2023

Midcareer Investigator Award in Patient-Oriented Research (Parent K24 – Independent Basic Experimental Studies with Humans Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 12, 2023

NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 12, 2023

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 12, 2023

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 12, 2023

Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required | USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 12, 2023

Tobacco Regulatory Science (R01 Clinical Trial Optional)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: August 6, 2023

Final closing date: October 6, 2023

NIH SIREN Neurologic Clinical Trials (UG3/UH3 – Clinical Trial Required) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 6, 2023

Final closing date: October 6, 2023

Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 5, 2023

Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: October 5, 2023

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 5, 2023

Final closing date: October 5, 2023

BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 4, 2023

Final closing date: October 4, 2023

Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: September 4, 2023

Final closing date: October 4, 2023

Comparative Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: August 13, 2023

Final closing date: September 27, 2023

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed | USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: August 25, 2023

Final closing date: September 25, 2023

NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: September 8, 2023

Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 25, 2023

Final closing date: August 25, 2023

Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 10, 2023

Final closing date: August 10, 2023

Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 9, 2023

Final closing date: August 9, 2023

Ruth L. Kirschstein Individual Predoctoral NRSA for MD/PhD and other Dual Degree Fellowships (USA biomedical research)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: August 8, 2023

Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 2, 2023

Final closing date: August 2, 2023

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: June 28, 2023

Final closing date: July 28, 2023

HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: June 10, 2023

Final closing date: July 10, 2023

Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed) (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: June 7, 2023

Final closing date: July 7, 2023

Roybal Centers for Translational Research on Aging (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: May 23, 2023

Final closing date: June 23, 2023

Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: May 20, 2023

Final closing date: June 20, 2023

Funder Perspective

No related blog.

Funder Event

Would you like to be included in our database?

Get in touch

research funder database

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.